Today there are more adolescents in the world than ever before: 1 in 6 of the world’s population. Nearly 90% of these adolescents live in low- and middle-income countries. More than half of the people in Kyrgyzstan, a post-Soviet, landlocked country in the heart of Central…
Persistent cognitive issues and the troubling brain scans of recovering COVID-19 patients have led researchers to explore whether coronavirus infection ups the risk of developing Alzheimer’s.
COVID-19’s mental health toll on health care workers has been documented—but what about public health workers? A new CDC survey shows that they experienced impacts comparable to other health workers.
During the pandemic, when he was often the only emergency room physician on duty at his Utah hospital, Scott Jolley reached a tipping point. He took a sabbatical in August 2020 and sought help, but Jolley’s story ended in tragedy with his suicide.
The US may be one of the planet’s most well-resourced countries, but it’s clearly doing a much worse job of providing health care—particularly mental health care—than many countries.
A new Alzheimer’s drug has secured FDA approval for the first time in nearly 2 decades, and not everyone is happy about it. Biogen’s new drug, Aduhelm, is expensive ($56,000 per year) and highly controversial:
Rates of teen depression have spiraled in the past decade—mental health researchers believe social media may have a large role to play,
Police mistake someone who is mentally ill as an immediate threat, and the person in crisis ends up dead at the hands of law enforcement.
Pain research has long relied on methods like the McGill Pain Questionnaire, which helps doctors treat pain by prompting patients to attach a certain vocabulary and meaning to it. But people with Alzheimer’s can be robbed of the cognitive ability to communicate their pain—…
As countries scramble to respond to the pandemic, mental health professionals are warning of an emerging youth mental health crisis,